Literature DB >> 27935664

Point-of-care assessment of C-reactive protein and white blood cell count to identify bacterial aetiologies in malaria-negative paediatric fevers in Tanzania.

Helena Hildenwall1,2, Florida Muro3, Jaqueline Jansson1, George Mtove4,5, Hugh Reyburn6, Ben Amos4.   

Abstract

OBJECTIVE: To assess the role of point-of-care (PoC) assessment of C-reactive protein (CRP) and white blood cell (WBC) count to identify bacterial illness in Tanzanian children with non-severe non-malarial fever.
METHODS: From the outpatient department of a district hospital in Tanzania, 428 patients between 3 months and 5 years of age who presented with fever and a negative malaria test were enrolled. All had a physical examination and bacterial cultures from blood and urine. Haemoglobin, CRP and WBC were measured by PoC devices.
RESULTS: Positive blood cultures were detected in 6/428 (1.4%) children and urine cultures were positive in 24/401 (6.0%). Mean WBC was similar in children with or without bacterial illness (14.0 × 109 , 95% CI 12.0-16.0 × 109 vs. 12.0 × 109 , 95% CI 11.4-12.7 × 109), while mean CRP was higher in children with bacterial illness (41.0 mg/l, 95% CI 28.3-53.6 vs. 23.8 mg/l, 95% CI 17.8-27.8). In ROC analysis, the optimum cut-off value for CRP to identify bacterial illness was 19 mg/l but with an area under the curve of only 0.62. Negative predictive values exceeded 80%, while positive predictive values were under 40%.
CONCLUSION: WBC and CRP levels had limited value in identifying children with bacterial infections. The positive predictive values for both tests were too low to be used as single tools for treatment decisions.
© 2016 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  C-reactive protein; children; fever; infection; leucocytes; point-of-care test

Mesh:

Substances:

Year:  2016        PMID: 27935664      PMCID: PMC5336187          DOI: 10.1111/tmi.12823

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


Introduction

Childhood febrile illnesses in resource‐poor settings are often treated presumptively with antibiotics and/or antimalarials due to the lack of diagnostic tools to differentiate between aetiologies. Since 2010, WHO recommend parasitological testing to guide antimalarial drug use wherever possible and the subsequent availability of malaria rapid diagnostic tests (RDTs) provides an opportunity for improved management of paediatric febrile illness 1, 2. However, inappropriate treatment of malaria‐negative patients continues 3. Where increased testing for malaria has been introduced, antibiotic prescribing is poorly targeted and often increased 4, 5, 6, in spite of evidence that many of these infections are viral 7, 8, 9. Levels of C‐reactive protein (CRP) and white blood cells (WBC) can be assessed by point‐of‐care (PoC) tests that may differentiate between bacterial and viral illnesses, but results remain inconclusive 10, 11, 12, 13, 14. Despite these disparities in results, WBC and CRP are commonly used in high‐income settings and may be valuable to reduce numbers of blood cultures in hospitalised children or limit antibiotic use in outpatients 15, 16. To our knowledge, the potential for CRP and WBC to identify bacterial infections in non‐severe paediatric fevers has not been clarified in sub‐Saharan Africa.

Methods

Study area

Data collection took place at St Augustine's Hospital (formally Teule Hospital), Muheza District, Tanzania, from July 2011 until November 2012. St Augustine's Hospital primarily covers a rural population where malaria transmission is perennial with increased transmission during the two rainy seasons. There has been a considerable decline in the prevalence of Plasmodium falciparum in recent years 17. Patient residency in one of the 85 villages from which there had been more than 10 paediatric admissions to St Augustine's Hospital in 2006 was used to define the study area.

Procedures

Patients were recruited at the hospital's Reproductive and Child Health clinic. Patients between 3 months and 5 years of age were consecutively recruited to enter a first and second screening. The first screening assessed children for presence of fever on that day or the day before, residency in the study area and absence of life‐threatening illness, as defined in the Integrated Management of Childhood Illness (IMCI) algorithm 18. In the second screening, patients were excluded if they suffered from an obvious soft tissue infection, if they presented with a chronic condition except HIV infection – which was only recorded if reported by the patient's guardian – and if the patient had already been enrolled in the same study within the previous month. A negative rapid test for P. falciparum (Paracheck™; Orchid Biomedical, Mumbai) was required to enter the study. If a child was eligible for enrolment, the study information was read to the patient's guardian, and after informed consent had been obtained, a clinical history and examination were recorded by a study clinical officer using the IMCI algorithm 18. Enrolled patients were asked to return to the hospital for scheduled follow‐up visits after 1 and 2 weeks to collect data on symptom progression as reported in a related publication 9.

Laboratory procedures

A maximum of 10 ml of blood was drawn from all enrolled patients through sterile venepuncture using a butterfly and syringe. At least 3–6 ml of blood was aseptically inoculated into a BactALERT (BioMerieux, France) paediatric FAN aerobic culture bottle. All cultures with growth of a suspected or verified pathogen were immediately reported back to the clinicians to allow for treatment adjustments of affected patients. Detailed information on blood culture procedures and results is reported in a related publication 9. Remaining venous blood was used for PoC measurement of haemoglobin (HemoCue™, Ängelholm, Sweden), CRP (Afinion AS100 Analyzer™; Axis‐Shield, Oslo, Norway) and white blood cell count (HemoCue™, Ängelholm, Sweden). CRP results less than 5 mg/l were reported by the machine as <5 mg/l, while results higher than 200 mg/l were reported as >200 mg/l. CRP results above 100 mg/l were repeated to confirm results but did not have any impact on management decisions. Urine samples were obtained by clean catch collection at enrolment. Careful instructions for cleaning before sample collection were given to all caretakers to avoid skin pathogen contamination of urine samples. Urine was collected in sterile bottles and a Multistix dipstick was performed immediately upon receiving the urine. If nitrate‐ or leucocyte‐positive, the urine was sent for bacterial culture within 1 h of collection. A growth of 105 colony‐forming units (cfu) per ml was considered significant bacteriuria. If a urine culture resulted in two or more colony types at greater than 105/ml, it was reported as contaminated and a repeat specimen requested. Bacillus species and coagulase‐negative organisms other than Staphylococcus saprophyticus were reported as contaminants and not further identified.

Data management and analysis

For the analysis of relations between CRP/WBC levels and bacterial infections, we defined potential bacterial infections as either a positive urine or blood culture or symptoms suggestive of IMCI pneumonia as defined in the IMCI algorithm during the study period, for example cough or difficult breathing with a respiratory rate of >40 breaths/min for children older than 1 year and >50 breaths/min for children below 1 year of age 18. Data were manually double‐entered in MS Access and analysed using Dell Statistica version 13 and Stata 12 software. Proportions with confidence intervals were calculated for prevalence of clinical characteristics. Wilcoxon rank‐sum test was used to compare continuous variables between groups, and Mann–Whitney U‐test with receiver operator characteristic was used to identify cut‐off values for CRP/WBC to predict bacterial illness.

Ethics

Written informed consent to participate was obtained from the parent or legal guardian of each child in the study. The Ethical Review Boards of the National Institute for Medical Research in Tanzania approved the study including the consent procedures.

Results

A total of 428 patients between 3 months and 5 years of age were enrolled in the study. Figure 1 shows a flow chart of screening procedures. The most common symptom presented at enrolment was cough, reported in 279/428 (65.2%, 95% CI 60.7–69.7) children, while 60/428 (14.0%, 95% CI 10.7–17.3) children met the IMCI criteria for non‐severe pneumonia, that is cough or difficult breathing with an increased respiratory rate for age. A pathogen detected by blood culture was identified in 6/428 (1.4%, 95% CI 0.3–2.5). A total of 401/428 (93.7%, 95% CI 91.4–96.0) children provided a urine sample. Of these, 24/401 (6.0%, 95% CI 3.7–8.3) had a positive urine culture. Details of the bacteria identified in cultures are presented in Table S1. Table 1 shows additional background details on all enrolled by illness classification.
Figure 1

Study flow chart. As two children with Integrated Management of Childhood Illness (IMCI) pneumonia also had a positive urine culture and one child with IMCI pneumonia had a positive blood culture, the sum of all diagnoses is 431.

Table 1

Clinical characteristics of 428 children 3–59 months with malaria‐negative fever

No IMCI criteria of bacterial infection (N = 341)IMCI pneumoniaa (N = 60)Urine culture positive (N = 24)Blood culture positive (N = 6)
Age <12 months  n (%, 95% CI)  N = 174 126 (72.4, 65.8–79.0)31 (17.8, 12.1–23.5)16 (9.2, 4.9–13.5)4 (2.3, 0.1–4.6)
Age 1–5 years  n (%, 95% CI)  N = 254 215 (84.6, 80.2–89.1)29 (11.4, 7.5–15.3)8 (3.1, 1.0–5.0)2 (0.8, −0.3 to 1.9)
Females  n (%, 95% CI) 184 (54.0, 48.7–59.2)24 (40.0, 27.6–52.4)12 (50.0, 30.0–70.0)5 (83.3, 53.5–113.1)
Temp > 37.5  n (%, 95% CI) 142 (41.6, 36.4–46.8)44 (73.3, 62.1–84.5)8 (33.3, 14.5–52.2)4 (66.7, 28.9–104.4)
Days with fever  mean (median) 3.3 (3)2.9 (3)3.1 (3)5.5 (5.5)
Admitted  n (%, 95% CI) 8 (2.3, 0.7–3.9)17 (28.3, 16.9–39.7)01 (16.7, −13.1 to 46.5)

IMCI, Integrated Management of Childhood Illness.

As two children with IMCI pneumonia also had a positive urine culture and one child with IMCI pneumonia had a positive blood culture, the sum of all diagnoses is 431.

Study flow chart. As two children with Integrated Management of Childhood Illness (IMCI) pneumonia also had a positive urine culture and one child with IMCI pneumonia had a positive blood culture, the sum of all diagnoses is 431. Clinical characteristics of 428 children 3–59 months with malaria‐negative fever IMCI, Integrated Management of Childhood Illness. As two children with IMCI pneumonia also had a positive urine culture and one child with IMCI pneumonia had a positive blood culture, the sum of all diagnoses is 431. Table 2 provides information on mean and median values of haemoglobin, CRP and WBC depending on illness classification. WBC did not differ significantly between children with IMCI pneumonia/positive urine or blood culture (mean 14.0 × 109, 95% CI 12.0–16.0 × 109, median 13.5 × 109) and those without signs of bacterial infection (mean 12.0 × 109, 95% CI 11.4–12.7 × 109, median 11.5 × 109). CRP was significantly higher in children with IMCI pneumonia/positive urine or blood culture (mean 41.0 mg/l, 95% CI 28.3–53.6 median 16 mg/l) vs. children without any signs of bacterial infection (mean 23.8 mg/l, 95% CI 17.8–27.8, median 7 mg/l).
Table 2

Haemoglobin, C‐reactive protein and white blood cell median and mean values by illness classification

No IMCI criteria of bacterial infection (N = 341)IMCI pneumonia (N = 60)a Urine culture positive (N = 24)Blood culture positive (N = 6)
Haemoglobin g/dl mean (median) 11.1 (11.3)10.4 (10.6)10.5 (10.7)10.6 (10.9)
CRP mg/l mean (median) 23.8 (7)40.1 (13)45.0 (24)29.5 (22)
WBC ×109/l mean (median) 12.0 (11.5)13.8 (13.5)14.7 (13.4)9.2 (8.1)

IMCI, Integrated Management of Childhood Illness.

As two children with IMCI pneumonia also had a positive urine culture and one child with IMCI pneumonia had a positive blood culture, the sum of all diagnoses is 431.

Haemoglobin, C‐reactive protein and white blood cell median and mean values by illness classification IMCI, Integrated Management of Childhood Illness. As two children with IMCI pneumonia also had a positive urine culture and one child with IMCI pneumonia had a positive blood culture, the sum of all diagnoses is 431.

C‐reactive protein and bacterial infection

Overall, 256/428 (59.8%, 95% CI 55.2–64.5) children had a CRP value of less than 20 mg/l. Of these, 215/256 (84.0%, 95% CI 79.5–88.5) were children with no signs of bacterial infection, that is no positive blood or urine culture and no IMCI pneumonia. Applying a cut‐off value of CRP at 20 mg/l, the negative likelihood ratio for either a positive blood or urine culture or IMCI pneumonia was 0.71 (95% CI 0.57–0.87). The negative likelihood ratio for a positive urine culture with a CRP below 20 was 0.55 (95% CI 0.33–0.90) and for a positive blood culture 0.64 (95% CI 0.24–1.70). Nevertheless, nine children with a positive urine culture had a CRP below 20 mg/l and two children with a positive blood culture had a CRP below 5 mg/l. None of these presented with any severity signs as defined in the IMCI algorithm, and the fever had reportedly been present for at least two days. Of all enrolled, 33/428 (7.7%, 95% CI 5.2–10.2) had a CRP level above 80 mg/l. Twelve of these 33 (36.7%, 95% CI 20.3–53.1) had some sign of bacterial infection (positive urine or blood culture or IMCI pneumonia). Repeat CRP tests were carried out in 29 patients, and 12 (41.4%) of these showed a similar result of >200 mg/l in both tests. The ROC analysis suggested a cut‐off for CRP of 19 mg/l to differentiate between children with and without signs of bacterial infection, for example positive urine/blood culture or IMCI pneumonia, but the area under the curve (AUC) was low at only 0.62. Similar cut‐offs and AUC values were yielded in separate ROC analysis for blood cultures, urine cultures and IMCI pneumonias, respectively (Figure 2).
Figure 2

ROC curves for C‐reactive protein (mg/l) in relation to (a) positive urine culture, (b) positive blood culture, (c) IMCI pneumonia and (d) all suspected bacterial infections.

ROC curves for C‐reactive protein (mg/l) in relation to (a) positive urine culture, (b) positive blood culture, (c) IMCI pneumonia and (d) all suspected bacterial infections.

White blood cell density and bacterial infection

Seventeen patients had a WBC of above 20 × 109/l. Most of these (13/17, 76.5%, 95% CI 56.3–96.7) had no signs of bacterial infection. There were no tendencies of higher WBC counts in children with positive urine or blood culture nor among children with IMCI pneumonia, and the AUC in ROC analysis was low at 0.52 (Figure 3).
Figure 3

ROC curve for white blood cells (×109) in relation to all suspected bacterial infections.

ROC curve for white blood cells (×109) in relation to all suspected bacterial infections. Based on the cut‐off values for CRP and WBC identified in the ROC analysis, sensitivity, specificity and positive and negative predictive values (NPV) were calculated (Table 3). For both CRP and WBC, NPV reached above 80% – mainly explained by the low prevalence of positive cultures – while positive predictive values were all less than 35.9%.
Table 3

Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of CRP 19 mg/l and WBC <5.0a or >17.4 × 109 to predict paediatric infections

VariableCut‐off pointIllness causeSensitivity (%, 95% CI)Specificity (%, 95% CI)PPV (%, 95% CI)NPV (%, 95% CI)
CRP19 mg/lAll44.6 (33.2–56.6)78.5 (73.0–83.1)35.9 (26.3–46.6)84.0 (78.8–88.1)
UTI57.1 (34.4–77.4)78.4 (72.6–83.1)17.9 (9.9–29.6)95.7 (91.7–97.9)
Bacteraemia50.0 (9.2–90.8)78.5 (73.0–83.1)3.3 (0.6–12.1)99.1 (96.4–99.8)
IMCI pneumonia37.5 (24.3–52.7)78.5 (73.0–83.1)23.4 (14.8–34.7)87.8 (82.8–91.5)
WBC<5.0 or >17.4 × 109 All27.8 (14.8–45.4)83.7 (77.9–88.3)22.7 (12.0–38.2)87.1 (81.4–91.2)
UTI40.0 (13.7–72.6)82.9 (77.3–87.4)9.1 (3.0–22.6)97.0 (93.3–98.8)
Bacteraemia33.3 (1.8–87.5)83.7 (77.9–88.3)2.9 (0.1–16.6)98.9 (95.5–99.8)
IMCI pneumonia23.8 (9.1–47.5)83.7 (77.9–88.3)12.8 (4.8–28.2)91.6 (86.5–95.0)

IMCI, Integrated Management of Childhood Illness.

As some bacterial infections present with a low WBC, we also used a lower cut‐off limit for WBC.

Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of CRP 19 mg/l and WBC <5.0a or >17.4 × 109 to predict paediatric infections IMCI, Integrated Management of Childhood Illness. As some bacterial infections present with a low WBC, we also used a lower cut‐off limit for WBC.

Discussion

Point‐of‐care bring a number of advantages that are particularly relevant to resource‐poor countries such as their simplicity and independence from distant laboratories or complex quality control systems. However, PoC tests come at a cost, both financial and in health worker time, and their use must be justified by evidence. In this study, we found that the measurement of white blood cells and CRP did not facilitate diagnosis of bacterial illness in children with malaria‐negative fever in Tanzania. As a single indicator of bacterial infection, both WBC and CRP did not provide sufficient accuracy to justify their use in assessing children with non‐severe febrile illness. Assessment of white blood cells failed to show any significant difference between children with and without suspected bacterial infections. The use of white blood cell differential count has a long history of use as a diagnostic marker of bacterial illness but in recent studies has shown poor specificity and sensitivity in a review of potential biomarkers to identify serious bacterial illness 19. This study confirms the limited diagnostic use of WBC testing in paediatric fevers in resource‐poor settings. In comparison, CRP values were generally higher among children with suspected or confirmed bacterial illness than among children without any signs of bacterial illness. The cut‐offs in ROC analysis were around 20 mg/l for IMCI pneumonia as well as for confirmed positive urine or blood cultures, but as in other studies, the AUC values were too poor for the cut‐off value to be trusted 14, 20. Notably, the suggested cut‐off and AUC values were similar for IMCI pneumonia and confirmed positive blood cultures. This is despite the fact that the IMCI algorithm for pneumonia used in 2011/12 is known to overdiagnose pneumonia. In other studies, the use of CRP assessment has proven useful to predict radiologically confirmed pneumonia, and even to differentiate viral from bacterial causes 8, 12, 21, 22. Results from these previous studies have suggested higher cut‐off values of CRP in pneumonia than the one in this study, the value perhaps being lower due to the incomplete availability of X‐rays. The current IMCI algorithm does not include any suggestions on how to diagnose urinary tract infections although these infections contribute to more than 5% of paediatric fevers 9. Urine dipsticks have been suggested as part of a refined algorithm to assess paediatric fevers in low‐resource settings, but sampling of urine is time‐consuming and samples are easily contaminated 23. Considering the relatively high NPV of CRP for urinary tract infections, a combination of urine dipstick and CRP assessment may be useful to improve diagnostic accuracy of paediatric urinary tract infections and in particular contribute to the identification of children with upper urinary tract infections and risks of renal scarring 24. The suggested cut‐off in ROC analysis for CRP levels to consider bacterial illness was 19 mg/l. This is similar to the proposed cut‐off value of 20 mg/l to rule out severe bacterial infection in a systematic review of paediatric fevers 25. Still, some children who were admitted had a normal CRP level, for example below 5 mg/l, despite being sick enough to require admission. While none of these children had features specific to bacterial disease and thus may have suffered viral infections, it highlights the importance of not relying on a single marker in the assessment of a sick child but rather combines different diagnostic tools to decide on how the illness should be managed. The low prevalence of positive blood cultures in outpatients will inevitably result in very low positive predictive values of anything other than a very accurate test and makes it unlikely that any single symptom or biomarker alone can guide treatment when assessing a febrile child.

Study limitations

We excluded patients with a positive malaria RDT in this study as earlier studies have shown the inability of CRP/WBC to differentiate between malaria and bacterial infections despite tendencies of higher values in bacterial infections 26. Urine cultures were only performed on children with a dipstick positive for leucocytes and/or nitrate, and we may thus have missed some urinary tract infections without pathologic results on urine dipsticks. Furthermore, as RDTs may remain positive after the malaria illness has resolved, there is a risk that some patients with a positive RDT also suffered bacterial/viral illness and were incorrectly excluded. The use of IMCI pneumonia as a proxy for bacterial pneumonia diagnosis is known to overestimate pneumonia but was used as high‐quality X‐rays were only available for 50% of included children. The rather low percentage of IMCI pneumonias compared to other studies may be partly due to an intense training of research staff to count respiratory rate properly but may also be influenced by the inclusion criteria requiring fever today or yesterday to enter the study, possibly decreasing the overall severity of illness in the group. As serological tests were not carried out, some patients may have suffered from zoonoses in which CRP/WBC levels remain unknown 27. Furthermore, the normal distribution of CRP may differ between different areas and also seem to be affected by malaria endemicity as well as genetic factors that may limit generalisability and call for local cut‐off recommendations 28, 29. The Afinion CRP analyser can only work in a temperature range between 15 and 32°C, which obviously constitutes a limitation for PoC analysis of CRP in tropical settings in general.

Conclusions

We conclude that assessment of WBC count had a limited value in the identification of children with bacterial infections in non‐malarial fevers presenting to an outpatient department. Both CRP and WBC measurements resulted in positive predictive values that were too low to be used as a single tool for treatment decisions. Table S1. Bacterial aetiologies in blood cultures and urine cultures. Click here for additional data file.
  26 in total

1.  Comparison of oral amoxicillin with placebo for the treatment of world health organization-defined nonsevere pneumonia in children aged 2-59 months: a multicenter, double-blind, randomized, placebo-controlled trial in pakistan.

Authors:  Tabish Hazir; Yasir Bin Nisar; Saleem Abbasi; Yusra Pervaiz Ashraf; Joza Khurshid; Perveen Tariq; Rai Asghar; Asifa Murtaza; Tahir Masood; Sajid Maqbool
Journal:  Clin Infect Dis       Date:  2010-12-28       Impact factor: 9.079

Review 2.  Fever in the new millennium: a review of recent studies of markers of serious bacterial infection in febrile children.

Authors:  Allen L Hsiao; M Douglas Baker
Journal:  Curr Opin Pediatr       Date:  2005-02       Impact factor: 2.856

3.  Do high levels of C-reactive protein in Tanzanian children indicate malaria morbidity.

Authors:  N Hurt; T Smith; T Teuscher; M Tanner
Journal:  Clin Diagn Lab Immunol       Date:  1994-07

4.  C-reactive protein in viral and bacterial respiratory infection in children.

Authors:  M Korppi; L Kröger
Journal:  Scand J Infect Dis       Date:  1993

5.  Integrated paediatric fever management and antibiotic over-treatment in Malawi health facilities: data mining a national facility census.

Authors:  Emily White Johansson; Katarina Ekholm Selling; Humphreys Nsona; Bonnie Mappin; Peter W Gething; Max Petzold; Stefan Swartling Peterson; Helena Hildenwall
Journal:  Malar J       Date:  2016-08-04       Impact factor: 2.979

6.  Marked differences in CRP genotype frequencies between the Fulani and sympatric ethnic groups in Africa.

Authors:  Elisabeth Israelsson; Mattias Ekström; Amre Nasr; Amagana Dolo; Susannah Kearsley; Gishanthi Arambepola; Manijeh Vafa Homann; Bakary Maiga; Ogobara K Doumbo; Gehad Elghazali; Hayder A Giha; Marita Troye-Blomberg; Klavs Berzins; Per Tornvall
Journal:  Malar J       Date:  2009-06-22       Impact factor: 2.979

7.  Influence of rapid malaria diagnostic tests on treatment and health outcome in fever patients, Zanzibar: a crossover validation study.

Authors:  Mwinyi I Msellem; Andreas Mårtensson; Guida Rotllant; Achuyt Bhattarai; Johan Strömberg; Elizeus Kahigwa; Montse Garcia; Max Petzold; Peter Olumese; Abdullah Ali; Anders Björkman
Journal:  PLoS Med       Date:  2009-04-28       Impact factor: 11.069

8.  Procalcitonin and C-reactive protein in urinary tract infection diagnosis.

Authors:  Rui-Ying Xu; Hua-Wei Liu; Ji-Ling Liu; Jun-Hua Dong
Journal:  BMC Urol       Date:  2014-05-30       Impact factor: 2.264

9.  Causes of non-malarial febrile illness in outpatients in Tanzania.

Authors:  Helena Hildenwall; Ben Amos; George Mtove; Florida Muro; Kerstin Cederlund; Hugh Reyburn
Journal:  Trop Med Int Health       Date:  2015-11-26       Impact factor: 2.622

10.  Acute Uncomplicated Febrile Illness in Children Aged 2-59 months in Zanzibar - Aetiologies, Antibiotic Treatment and Outcome.

Authors:  Kristina Elfving; Deler Shakely; Maria Andersson; Kimberly Baltzell; Abdullah S Ali; Marc Bachelard; Kerstin I Falk; Annika Ljung; Mwinyi I Msellem; Rahila S Omar; Philippe Parola; Weiping Xu; Max Petzold; Birger Trollfors; Anders Björkman; Magnus Lindh; Andreas Mårtensson
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

View more
  9 in total

1.  Usefulness of C-Reactive Protein and Other Host BioMarker Point-of-Care Tests in the Assessment of Non-Malarial Acute Febrile Illnesses: A Systematic Review with Meta-Analysis.

Authors:  Giulia Bertoli; Niccolò Ronzoni; Ronaldo Silva; Michele Spinicci; Chiara Perlini; Luca Omega; Tamara Ursini; Alessandro Bartoloni; Piero Olliaro; Zeno Bisoffi; Dora Buonfrate
Journal:  Am J Trop Med Hyg       Date:  2020-11       Impact factor: 2.345

2.  Sensitivity of C-reactive protein for the identification of patients with laboratory-confirmed bacterial infections in northern Tanzania.

Authors:  Thomas Althaus; Yoel Lubell; Venance P Maro; Blandina T Mmbaga; Bingileki Lwezaula; Christine Halleux; Holly M Biggs; Renee L Galloway; Robyn A Stoddard; Jamie L Perniciaro; William L Nicholson; Kelly Doyle; Piero Olliaro; John A Crump; Matthew P Rubach
Journal:  Trop Med Int Health       Date:  2020-01-06       Impact factor: 2.622

3.  The social role of C-reactive protein point-of-care testing to guide antibiotic prescription in Northern Thailand.

Authors:  Marco J Haenssgen; Nutcha Charoenboon; Thomas Althaus; Rachel C Greer; Daranee Intralawan; Yoel Lubell
Journal:  Soc Sci Med       Date:  2018-02-23       Impact factor: 4.634

4.  Incidence and Risk Factors for Severe Pneumonia in Children Hospitalized with Pneumonia in Ujjain, India.

Authors:  Sunil Kumar Kasundriya; Mamta Dhaneria; Aditya Mathur; Ashish Pathak
Journal:  Int J Environ Res Public Health       Date:  2020-06-27       Impact factor: 3.390

5.  How context can impact clinical trials: a multi-country qualitative case study comparison of diagnostic biomarker test interventions.

Authors:  Marco J Haenssgen; Nutcha Charoenboon; Nga T T Do; Thomas Althaus; Yuzana Khine Zaw; Heiman F L Wertheim; Yoel Lubell
Journal:  Trials       Date:  2019-02-08       Impact factor: 2.279

6.  Performance of prediction rules and guidelines in detecting serious bacterial infections among Tanzanian febrile children.

Authors:  Kristina Keitel; Mary Kilowoko; Esther Kyungu; Blaise Genton; Valérie D'Acremont
Journal:  BMC Infect Dis       Date:  2019-09-03       Impact factor: 3.090

7.  A Comparison of Patients' Local Conceptions of Illness and Medicines in the Context of C-Reactive Protein Biomarker Testing in Chiang Rai and Yangon.

Authors:  Yuzana Khine Zaw; Nutcha Charoenboon; Marco J Haenssgen; Yoel Lubell
Journal:  Am J Trop Med Hyg       Date:  2018-04-05       Impact factor: 2.345

Review 8.  The good and the bad: using C reactive protein to distinguish bacterial from non-bacterial infection among febrile patients in low-resource settings.

Authors:  Camille Escadafal; Sandra Incardona; B Leticia Fernandez-Carballo; Sabine Dittrich
Journal:  BMJ Glob Health       Date:  2020-05

9.  Tanzanian primary healthcare workers' experiences of antibiotic prescription and understanding of antibiotic resistance in common childhood infections: a qualitative phenomenographic study.

Authors:  Matilda Emgård; Rose Mwangi; Celina Mayo; Ester Mshana; Gertrud Nkini; Rune Andersson; Sia E Msuya; Margret Lepp; Florida Muro; Susann Skovbjerg
Journal:  Antimicrob Resist Infect Control       Date:  2021-06-27       Impact factor: 4.887

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.